본문 바로가기
KERD
논문KCI 등재

비만 유도 흰쥐 간조직에서 太陰調胃湯 加減方이 당과 지질대사에 미치는 영향

Effects of Taeumjowe-tang-gagambang on the Glycometabolism and Lipidmetabolism in the Liver Tissue of Diet-induced Obesity Mice

최유경|박종형|고성규|전찬용|소미혜
한의병리학회 (The Society of Pathology in Korean Medicine)|2010.08|동의생리병리학회지 (Journal of Physiology & Pathology in Korean Medicine)|제24권 제4호|pp. 638-645

0

조회

0

다운로드

6

인용

0

참고문헌

키워드

metabolic syndromeIL-6TNF-aSREBP-1cTaeumjowe-tang-gagambang (TJV)
주제분류한의학

초록

The aim of this study was to investigate the effect of Taeeumjowuitanggagam-bang (TJV) on the mRNA expression of Sterol regulatory element binding proteins (SREBPs), Tumor necrosis factor-α (TNF-α) and Interlukin-6 (IL-6) that are considered to play an important role in lipid and glucose metabolism. For diet-induced obese studies, we split mice into 2 groups. The low fat diet group (LFD, n=8) were supplied with general diet for 10 weeks and the high fat diet group (HFD, n=18) were supplied with 60 ㎉％ fat diet for 10 weeks. And then The HFD group, the diet-induced obese group, were divided into 3 groups ; a group supplied with normal saline, a group treated with TJV 200 mg/kg and a group treated with TJV 500 mg/kg. They were treated orally with TJV and measured their body weight every day during 10 weeks. After that, we measured mRNA expressions of TNF-α, IL-6 and SREBP-1c in liver, and blood concentrations of glucose, total cholesterol and triglyceride too. The results are as follows. The TJV reduced glucose and total cholesterol of blood concentration. The TJV reduced the mRNA expressions of TNF-α and SREBPs in liver. However, We couldn't find the TJV effects on the mRNA expression of IL-6, triglyceride blood concentration, and body weight among groups. The TJV stained liver tissue less red than control group. These results suggest that TJV may be effective for regulation of lipid and glucose metabolism in liver.

Abstract

The aim of this study was to investigate the effect of Taeeumjowuitanggagam-bang (TJV) on the mRNA expression of Sterol regulatory element binding proteins (SREBPs), Tumor necrosis factor-α (TNF-α) and Interlukin-6 (IL-6) that are considered to play an important role in lipid and glucose metabolism. For diet-induced obese studies, we split mice into 2 groups. The low fat diet group (LFD, n=8) were supplied with general diet for 10 weeks and the high fat diet group (HFD, n=18) were supplied with 60 ㎉％ fat diet for 10 weeks. And then The HFD group, the diet-induced obese group, were divided into 3 groups ; a group supplied with normal saline, a group treated with TJV 200 mg/kg and a group treated with TJV 500 mg/kg. They were treated orally with TJV and measured their body weight every day during 10 weeks. After that, we measured mRNA expressions of TNF-α, IL-6 and SREBP-1c in liver, and blood concentrations of glucose, total cholesterol and triglyceride too. The results are as follows. The TJV reduced glucose and total cholesterol of blood concentration. The TJV reduced the mRNA expressions of TNF-α and SREBPs in liver. However, We couldn't find the TJV effects on the mRNA expression of IL-6, triglyceride blood concentration, and body weight among groups. The TJV stained liver tissue less red than control group. These results suggest that TJV may be effective for regulation of lipid and glucose metabolism in liver.

참고문헌 (30)

  1. 김선미, "당뇨가 없고 정상체중을 가진 사람에서 비알콜성 지방간 질환과 대사성 증후군", 대한비만학회지, 15(1), pp.44~51 (2006)
  2. Kim, J.K, "Mechanism of Insulin Resistance in A-ZIP", F-1 Fatless Mice, 2000, pp.275(12), 8456~8460
  3. Scott, C.L, "Diagnosis, prevention, and intervention for the metabolic syndrome", Am J Cardiol, 92(1), pp.35~42 (2003)
  4. Scheen, A.J, "Current management strategies for coexisting diabetes mellitus and obesity", Drugs, 63(12), pp.1165~1184 (2003)
  5. Miller, J.L, "Insulin resistance syndrome. Description pathogenesis, and management", Postgrad Med, 113(5), pp.27~34 (2003)
  6. 오세용, "한국 남성 비알코올성 지방간에서 혈청 adipokine 농도 변화에 영향을 미치는 요인", 대한내과학회지, 71(1), pp.58~66 (2006), 대한내과학회
  7. Angulo, P, "Nonalcoholic Fatty liver disease", N Eng J Med, 346(16), pp.1221~1231 (2002)
  8. Horton, J.D, "Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice", Proc Natl Acad Sci., 95(11), pp.5987~5992 (1998)
  9. Foretz, M, "ADD1", SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucse, 1999, pp.19, 3760~3768
  10. Shimomura, I, "Differential Expression of Exons 1a and 1c in mRNAs for Sterol Regulatory Element Binding Protein-1 in Human and Mouse Organs and Cultured Cells", J Clin Invest, 99(5), pp.838~845 (1997)
  11. Brown, M.S, "The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor", Cell, 89(3), pp.331~340 (1997)
  12. Horton, J.D, "SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver", J Clin Invest. Cell, 109, pp.1125~1131 (2002)
  13. Halaas, J.L, "Weight-reducing effects of the plasma protein encoded by the obese gene", Science, 269(5223), pp.543~546 (1995)
  14. Yahagi, N, "Absence of sterol regulatory element-binding protein-1 (SREPB-1) ameliorates Jorates fatty livers but not obesity or insulin resistance in Lepob", Lepob mice, 2002, pp.277(22), 19353~19357
  15. Gil-Campos M, "Adiponectin, the missing link in insulin resistance and obesity", Clin Nutr, 23(5), pp.963~974 (2004)
  16. Lee, J.M, "The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes", J Int Med Res, 37(6), pp.1803~1812 (2009)
  17. Phillips, C.M, "Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components", J Clin Endocrinol Metab, 95(3), pp.1386~1394 (2010)
  18. Yudkin, J.S, "Inflammation, obesity, and the metabolic syndrome", Horm Metab Res, 39(10), pp.707~709 (2007)
  19. Lesmana, C.R, "Clinical picture, insulin resistance, and adipocytokines profiles of nonalcoholic steatohepatitis(NASH) patients in Indonesia", Acta Med Indones, 41(1), pp.6~10 (2009)
  20. Uysal, K.T, "Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function", Nature, 389(6651), pp.610~614 (1997)
  21. 조세왕, "太陰調胃湯이 비만유발 흰쥐의 체중감량, 혈청지질 및 UCP1 발현에 미치는 영향", 대한한의학회지, 25(2), pp.87~97 (2004), 대한한의학회
  22. 황미자, "2000년 이후 비만치료에 사용되는 처방 및 본초에 대한 문헌연구-麻黃을 중심으로", 대한한방비만학회지, 7(1), pp.39~54 (2007)
  23. 박경무, "태음조위탕 관련연구 분석", 한방비만학회지, 9(1), pp.23~36 (2009), 한방비만학회
  24. 신동준, "태음조위탕과 마황이 비만 백서의 Leptin에 미치는 영향", 사상체질의학회지, 13(1), pp.79~87 (2001)
  25. 이기주, "太陰調胃湯이 白鼠의 肥滿症 및 誘導肥滿細胞에 미치는 효과", 사상의학회지, 8(2), pp.219~238 (1996)
  26. 유진환, "운동과 태음조위탕 처방이 흰쥐의 간기능 효소와 간내 지방축적에 미치는 영향", 운동과학, 11(2), pp.345~357 (2002), 한국운동생리학회
  27. 김정환, "당뇨병이 없는 성인 여성에서 혈청 visfatin 농도와 비만 및 대사증후군과의 관련성", 대한비만학회지, 18(1), pp.15~23 (2009), 대한비만학회
  28. 이정찬, "신사상의학론2", pp.261~262 (2001), 木과土
  29. Marceau, P, "Liver pathology and the metabolic syndrome X in severe obesity", J Clin Endocrinol Metab, 84(5), pp.1513~1517 (1999)
  30. 윤태승, "알파-리포산이 HepG2 간세포에서 SREBP-1c 발현에 미치는 효과", 대한내분비학회지, 23(1), pp.27~34 (2008), 대한내분비학회

관련 논문AI추천

調胃升淸湯 추출액이 비만유도 쥐의 지질대사, 항산화계 및 염증반응계에 미치는 영향김병우, 오성원대한한방내과학회 · 대한한방내과학회지2013 · 제34권 제1호太陰調胃湯이 白鼠의 肥滿症 및 誘導肥滿細胞에 미치는 效果김경요, 이기주, 전병훈사상체질면역의학회 · 사상체질면역의학회지1996 · 제8권 제2호고지방식이로 유도된 비만 생쥐모델에서 저령차전자탕의 항비만 효과고영미, 곽진영, 안택원, 장순우사상체질면역의학회 · 사상체질면역의학회지2018 · 제30권 제2호육의감비탕 열수 추출물이 비만 및 고지혈증 유도 생쥐에 미치는 효과김정범, 송효남, 이현희한의병리학회 · 동의생리병리학회지2011 · 제25권 제6호방풍통성산이 고지방식이 유도 어린 비만 생쥐의 지방 축적에 미치는 영향김기봉, 안상현대한한방소아과학회 · 대한한방소아과학회지2024 · 제38권 제1호太陰調胃湯과 麻黃이 肥滿 白鼠의 Leptin에 미치는 影響김달래, 김선형, 신동준사상체질면역의학회 · 사상체질면역의학회지2001 · 제13권 제1호

이 간행물의 다른 논문 (16건)

피부 노화 및 피부 주름 관리에 대한 고찰남혜정, 이우건, 김윤범, 김진명, 전선우pp. 533-542국내 한약-양약 상호작용 연구논문 분석을 통한 상호작용 정보 현황파악 및 제공방안에 대한 연구신재국, 박수진, 권영규pp. 543-552한약의 방사선 부작용 억제효과에 관한 경향 분석이수진pp. 559-565장기이식에 관한 한의학적 개념 연구김병수, 이수진, 김경신pp. 571-579발아현미, 배양산삼 및 용안육 혼합 제제가 Pentobarbital로 유도된 수면시간에 미치는 영향오석흥, 조형권, 은재순, 오기완pp. 598-601
원문 보기